NACDS President and CEO Steven C. Anderson issued the following statement, upon the release of a U.S. Department of Health and Human Services (HHS) Fact Sheet describing decision-making underway about implications of the May 11, 2023, expiration of the current Public Health Emergency (PHE).
With the U.S. House of Representatives slated to consider legislation related to the pandemic this week, NACDS has an important message: constituents view the importance of pharmacy access as a lesson that must be learned from the past three years.
The NACDS-authored column previews the policy outlook for the coming year — and what lies ahead for the future of the industry.
Inclusion of the INFORM Consumers Act marks a major bipartisan step toward curbing the organized retail crime networks jeopardizing Americans’ safety.
NACDS details actions needed by Biden Administration and Congress to prevent forced rollback
Through NACDS 2023, the Association continues to advance consumer-empowered, community-focused health and wellness.
Next Tuesday’s election will decide a lot – including 435 U.S. Representatives, 35 U.S. Senators, 36 Governors, and more than 6,000 state legislators. Control of the U.S. House of Representatives and U.S. Senate hang in the balance.
Sustaining PREP Act pharmacy flexibilities through October 2024 will help keep patients and pharmacies from having to “guess” about issues related to pharmacy access.
CNBC quoted NACDS on its call for the Biden Administration to maintain patients’ access to pharmacies in the effort to keep COVID-19 and flu at bay.
Comments to Centers for Medicare & Medicaid Services call for enforcement of electronic prescribing of controlled substances requirements no later than January 1, 2023.
